MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT Trademark

Trademark Overview


On Friday, January 8, 2021, a trademark application was filed for MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT with the United States Patent and Trademark Office. The USPTO has given the MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT trademark a serial number of 90454793. The federal status of this trademark filing is REGISTERED as of Tuesday, December 13, 2022. This trademark is owned by The American Society of Gene & Cell Therapy. The MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Education & Entertainment Services categories with the following description:

Providing online non-downloadable journals in the field of gene vector engineering and production, targeted genome editing and engineering, cell reprogramming and directed differentiation of pluripotent cells, gene and cell vector delivery, biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine, gene and cell vector biodistribution and tracking, pharmacology and toxicology studies of new and next-generation vectors, cell isolation, engineering, culture, expansion, and transplantation, cell processing, storage, and banking for therapeutic application

Downloadable journals in the field of gene vector engineering and production, targeted genome editing and engineering, cell reprogramming and directed differentiation of pluripotent cells, gene and cell vector delivery, biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine, gene and cell vector biodistribution and tracking, pharmacology and toxicology studies of new and next-generation vectors, cell isolation, engineering, culture, expansion, and transplantation, cell processing, storage, and banking for therapeutic application
molecular therapy methods & clinical development

General Information


Serial Number90454793
Word MarkMOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT
Filing DateFriday, January 8, 2021
Status700 - REGISTERED
Status DateTuesday, December 13, 2022
Registration Number6920628
Registration DateTuesday, December 13, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2022

Trademark Statements


Goods and ServicesProviding online non-downloadable journals in the field of gene vector engineering and production, targeted genome editing and engineering, cell reprogramming and directed differentiation of pluripotent cells, gene and cell vector delivery, biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine, gene and cell vector biodistribution and tracking, pharmacology and toxicology studies of new and next-generation vectors, cell isolation, engineering, culture, expansion, and transplantation, cell processing, storage, and banking for therapeutic application
Goods and ServicesDownloadable journals in the field of gene vector engineering and production, targeted genome editing and engineering, cell reprogramming and directed differentiation of pluripotent cells, gene and cell vector delivery, biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine, gene and cell vector biodistribution and tracking, pharmacology and toxicology studies of new and next-generation vectors, cell isolation, engineering, culture, expansion, and transplantation, cell processing, storage, and banking for therapeutic application
Pseudo MarkMOLECULAR THERAPY METHODS AND CLINICAL DEVELOPMENT

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, April 8, 2021
Primary Code009
First Use Anywhere DateFriday, January 31, 2014
First Use In Commerce DateFriday, January 31, 2014

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, April 8, 2021
Primary Code041
First Use Anywhere DateFriday, January 31, 2014
First Use In Commerce DateFriday, January 31, 2014

Trademark Owner History


Party NameThe American Society of Gene & Cell Therapy
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaukesha, WI 53186

Party NameThe American Society of Gene & Cell Therapy
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaukesha, WI 53186

Party NameThe American Society of Gene & Cell Therapy
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaukesha, WI 53186

Trademark Events


Event DateEvent Description
Tuesday, December 13, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 13, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, September 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 23, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 25, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 25, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 25, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 24, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 24, 2021NON-FINAL ACTION E-MAILED
Saturday, April 24, 2021NON-FINAL ACTION WRITTEN
Thursday, April 22, 2021ASSIGNED TO EXAMINER
Thursday, April 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 12, 2021NEW APPLICATION ENTERED IN TRAM